8-KLeadership ChangesExhibits & Filings

NIKE, Inc. 8-K Report, Executive Changes (Nov 23, 2009)

Filed November 23, 2009For Securities:NKE

Summary

This 8-K filing by NIKE, Inc. (NKE) announces a significant change in its Board of Directors. Effective November 19, 2009, Dr. Phyllis M. Wise was appointed to the Board. Dr. Wise brings extensive experience in academia, holding a prominent position as Executive Vice President and Provost at the University of Washington, along with professorships in multiple scientific disciplines. Her background also includes leadership roles at other major universities and election to the Institute of Medicine. The appointment appears to be strategic, aimed at potentially enhancing the company's corporate governance and possibly aligning with its corporate responsibility initiatives, as Dr. Wise will also serve on the Company's Corporate Responsibility Committee. Investors should note that there were no undisclosed arrangements or related-party transactions concerning Dr. Wise's appointment, indicating a clean and transparent onboarding process.

Key Highlights

  • 1NIKE, Inc. appointed Dr. Phyllis M. Wise to its Board of Directors, effective November 19, 2009.
  • 2Dr. Wise brings a strong academic and leadership background, currently serving as Executive Vice President and Provost of the University of Washington.
  • 3Her expertise spans physiology, biology, obstetrics and gynecology, and neurobiology.
  • 4Dr. Wise has held significant positions at other leading universities, including the University of Maryland, University of Kentucky, and University of California Davis.
  • 5She is an elected member of the Institute of Medicine, signifying a high level of recognition in her field.
  • 6Dr. Wise will also be a member of NIKE's Corporate Responsibility Committee.
  • 7There are no disclosed related-party transactions or prior understandings associated with her appointment.

Frequently Asked Questions

Dr. Phyllis M. Wise is a highly accomplished academic leader, currently the Executive Vice President and Provost of the University of Washington, with extensive experience in scientific fields. She was appointed to NIKE's Board of Directors to potentially bring her expertise and perspective to the company's governance and strategic direction, particularly in areas related to corporate responsibility.

According to the filing, there were no prior arrangements or understandings regarding Dr. Wise's election, and there are no related-party transactions between NIKE and Dr. Wise. Her appointment is presented as a new, independent addition to the board.

Dr. Wise will be serving on the Company's Corporate Responsibility Committee, indicating a focus on the company's ethical and social impact initiatives.

Election to the Institute of Medicine (now the National Academy of Medicine) is a highly selective honor, recognizing individuals who have demonstrated outstanding professional achievement and made significant contributions to the fields of health and medicine. This suggests Dr. Wise possesses strong analytical skills, leadership qualities, and a deep understanding of complex scientific and potentially societal issues, which could be valuable to NIKE's board.